Top Banner
Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA) Treatment of Substance Treatment of Substance Involved Offenders in Involved Offenders in Criminal Justice Settings Criminal Justice Settings Challenges & Outcomes Challenges & Outcomes
39

Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Dec 14, 2015

Download

Documents

Blaine Henshaw
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Igor Koutsenok, MD, MSAssistant Professor of Psychiatry, UCSD,

Director,Center for Criminality & Addiction Research, Training & Application

(CCARTA)

Treatment of Substance Treatment of Substance Involved Offenders in Criminal Involved Offenders in Criminal

Justice Settings –Justice Settings –Challenges & OutcomesChallenges & Outcomes

Page 2: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Let’s start with some bad Let’s start with some bad newsnews

Page 3: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

California StatisticsCalifornia Statistics

172,785 in prison (1986: 39,373)172,785 in prison (1986: 39,373) Cost – $38 000 per inmateCost – $38 000 per inmate 117,136 on parole (1986: 19,780)117,136 on parole (1986: 19,780) Cost - $12 000 per paroleeCost - $12 000 per parolee 77% of males and 83% of females 77% of males and 83% of females

incarcerated in California have drug incarcerated in California have drug and alcohol problems.and alcohol problems.

Page 4: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Nationwide costNationwide costColumbia University Report, March Columbia University Report, March

20052005

$ 30 billion states spent on adult $ 30 billion states spent on adult corrections (incarceration, corrections (incarceration, probation, parole)probation, parole)

$24.1 billion of it was on substance $24.1 billion of it was on substance involved offendersinvolved offenders

Page 5: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

During the 1980s and 1990s, the number of incarcerated women tripled, while the number of men doubled.

80% of these women have substance abuse problems.

On Women…On Women…

“What Works,” Dr. Rudy J. Cypser, CURE-NY, 2000

Page 6: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Some Other Sad FactsSome Other Sad Facts Over 2 million inmates inhabited U.S. Over 2 million inmates inhabited U.S.

jails & prisonsjails & prisons They are parents of 3.4 million childrenThey are parents of 3.4 million children 2 in 3 convicts have been tested 2 in 3 convicts have been tested

positive for drugs at time of arrest.positive for drugs at time of arrest. 2 in 3 inmates have verified drug 2 in 3 inmates have verified drug

histories, histories, BUT…BUT…

Under 15 % receive systematic Under 15 % receive systematic treatmenttreatment

Deitch, Koutsenok & Ruiz, 2004Deitch, Koutsenok & Ruiz, 2004

Page 7: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Recidivism Recidivism Within 12 months after release from Within 12 months after release from

custody 70- 75% of substance involved custody 70- 75% of substance involved offenders are back to institutionsoffenders are back to institutions

It is clear that criminal-justice It is clear that criminal-justice sanctions by themselves do not reduce sanctions by themselves do not reduce recidivism in this populationrecidivism in this population

Prisons do manage behaviors, but do Prisons do manage behaviors, but do not shape behaviorsnot shape behaviors

Page 8: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

Page 9: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

Public Safety

Public Safety RisksRisks

Page 10: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

$$$$$$ Costs $$$$$$$$

$$$$$$ Costs $$$$$$$$

$$

Public Safety Risks

Public Safety Risks

Page 11: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

Over-Over-reliancereliance

Page 12: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

PrisonPrison

Criminal Recidivism in 3 YearsCriminal Recidivism in 3 Years 68% re-arrested68% re-arrested 47% convicted47% convicted 50% re-incarcerated50% re-incarcerated

Relapse to Drug Use in 3 YearsRelapse to Drug Use in 3 Years 95% relapse95% relapse

Marlow D., Treatment Research Institute, 2006

Page 13: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

Page 14: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Policies for Drug OffendersPolicies for Drug Offenders

Diversion Incarceration

Probation w/o verdict(Prop 36)

Drug Courts

Intermediatesanctions

Over-Over-reliancereliance

Page 15: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Referral to TreatmentReferral to Treatment

50% - 67% don’t show for intake50% - 67% don’t show for intake 40% - 80% drop out in 3 months40% - 80% drop out in 3 months 90% drop out in 12 months90% drop out in 12 months 70% of probationers and parolees 70% of probationers and parolees

drop out within 2 - 6 monthsdrop out within 2 - 6 months

Attrition

D. Marlow D. & T.McLellan, TRI, 2004

Page 16: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Time for some better Time for some better newsnews

What will happen if we

What will happen if we

combine incarceration

combine incarceration

and treatment?

and treatment?

Page 17: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

From the work of From the work of Douglas B. Marlowe, J.D., Ph.D.Douglas B. Marlowe, J.D., Ph.D.

Types of Substance Types of Substance Involved OffendersInvolved Offenders

Page 18: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic RisksRisks Age during rehabilitation < 25 yearsAge during rehabilitation < 25 years Criminal onset < 16 yearsCriminal onset < 16 years Prior rehabilitation failuresPrior rehabilitation failures History of violenceHistory of violence Antisocial Personality DisorderAntisocial Personality Disorder Psychopathy Psychopathy Familial history of crimeFamilial history of crime Criminal associationsCriminal associations

Page 19: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction

Page 20: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

Page 21: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

} Abstinence is a distal goal

Page 22: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

Drug Abuse or MisuseDrug Abuse or Misuse

} Abstinence is a distal goal

Page 23: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

Drug Abuse or MisuseDrug Abuse or Misuse

} Abstinence is a distal goal

Abstinence is a proximal goal}

Page 24: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

Drug Abuse or MisuseDrug Abuse or Misuse

Collateral needsCollateral needs– E.g., dual diagnosis, HIV+E.g., dual diagnosis, HIV+

} Abstinence is a distal goal

Abstinence is a proximal goal}

Page 25: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Criminogenic Criminogenic NeedsNeeds

Drug Dependence or AddictionDrug Dependence or Addiction1.1. Binge patternBinge pattern2.2. Cravings or compulsionsCravings or compulsions3.3. Withdrawal symptomsWithdrawal symptoms

Drug Abuse or MisuseDrug Abuse or Misuse

Collateral needsCollateral needs– E.g., dual diagnosis, HIV+E.g., dual diagnosis, HIV+

} Abstinence is a distal goal

Abstinence is a proximal goal}

Page 26: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

Risk & Needs MatrixRisk & Needs Matrix

Page 27: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Risk & Needs MatrixRisk & Needs Matrix

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

AccountabilityAccountability&&

TreatmentTreatment

Page 28: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Risk & Needs MatrixRisk & Needs Matrix

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

AccountabilityAccountability&&

TreatmentTreatment

TreatmentTreatment

Page 29: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Risk & Needs MatrixRisk & Needs Matrix

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

AccountabilityAccountability&&

TreatmentTreatment

TreatmentTreatment

AccountabilityAccountability

Page 30: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Risk & Needs MatrixRisk & Needs Matrix

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

AccountabilityAccountability&&

TreatmentTreatment

TreatmentTreatment

PreventionPrevention

AccountabilityAccountability

Page 31: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Practice ImplicationsPractice Implications

High RiskHigh Risk Low RiskLow Risk

High High NeedsNeeds

Low Low NeedsNeeds

Frequent meetings Frequent meetings

with PAwith PA Intensive treatmentIntensive treatment ComplianceCompliance is proximal is proximal Positive reinforcementPositive reinforcement

Intensive treatment Intensive treatment TreatmentTreatment is proximal is proximal Positive reinforcementPositive reinforcement

AbstinenceAbstinence is proximal is proximal Restrictive sanctionsRestrictive sanctions

Secondary prevention Secondary prevention AbstinenceAbstinence is proximal is proximal

Page 32: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

The profile of a successful The profile of a successful high risk/high need client in high risk/high need client in

community based community based therapeutic community is therapeutic community is

very similar to the one of a very similar to the one of a substance abusing offender substance abusing offender

in custodyin custody

Why Therapeutic Community Model?

Page 33: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Delaware/Crest Program: Delaware/Crest Program: 3-Year Re-Arrest & Drug Use Rates3-Year Re-Arrest & Drug Use Rates

71

95

72

83

51

73

29

41

No Treatment

(n=210)

ITC Dropout*(n=109)

ITC, but noAftercare*

(n=101)

ITC +Aftercare*

(n=69)

% with New Arrests% with Drug Use

Martin, Butzin, Saum, & Inciardi, 2001 (The Prison Journal)

*p<.05

Page 34: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Texas In-prison TC ProgramTexas In-prison TC Program::Return to custody rates (24 months follow-up), 2001Return to custody rates (24 months follow-up), 2001

64

51

2319

33

22

16

3338

45

12

22

27

5

18

0

10

20

30

40

50

60

70

Intake 3 6 9 12 18 24

Months After Discharge

Untreated Comparisons (n=103)Aftercare Non-completers (n=123)Aftercare Completers (n=170)

AftercareCompleters

K. Knight, D. Simpson. The Prison Journal, 2002

Page 35: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

California/Amity Program: California/Amity Program: 3-Year Return-to-Custody Rates (%)3-Year Return-to-Custody Rates (%)

7582 79

28

No Treatment

(n=189)

ITC Dropout(n=73)

ITC, but noAftercare(n=154)

ITC +Aftercare*

(n=162)

Wexler, Melnick, Lowe, & Peters, 2002 (The Prison Journal)

*p<.001

Page 36: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Coercion in the CriminalCoercion in the Criminal Justice System Justice System

A 2000 report from the Institute A 2000 report from the Institute of Medicine summarized that of Medicine summarized that

“contrary to earlier fears among “contrary to earlier fears among clinicians, criminal justice clinicians, criminal justice

pressure does not threaten pressure does not threaten treatment effectiveness, and it treatment effectiveness, and it

improves outcomes”improves outcomes”

Page 37: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Research FindingsResearch FindingsMultiple studiesMultiple studies

The length of time spent in treatment is a reliable predictor of post treatment outcomes and recidivism

Coerced patients tend to stay longer and do as well as volunteers overall

Most substance involved offenders would never seek treatment without pressure from the criminal-justice system

Page 38: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

General Findings & Recommendations

1. Duration, Setting, Training: fundamental for In-prison TC (ITC) programs– ITC = 9-12 months in a residential (segregated)

treatment unit– Staff training is a must– On-going monitoring & evaluation

2. Engagement in transitional aftercare is crucial for effectiveness

3. ITC is most cost effective for high-risk offenders4. Boot camps & periodic drug-focused counseling

have poor outcomes5. Risk assessments should guide selections for Risk assessments should guide selections for

treatmenttreatment

Page 39: Igor Koutsenok, MD, MS Assistant Professor of Psychiatry, UCSD, Director, Center for Criminality & Addiction Research, Training & Application (CCARTA)

Thank youThank you